pocketful logo
Omaxe Ltd logo

Omaxe Ltd

NSE: OMAXE BSE: 532880

72.05

(1.67%)

Sat, 21 Mar 2026, 06:56 pm

Omaxe Analysis

dividend

thumbs up icon

Pros

    thumbs up icon

    Cons

    • Omaxe is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
    • No need to calculate the sustainability of Omaxe's dividends as it is not paying a notable one for India.
    • Omaxe is not paying a notable dividend for India, therefore no need to check if the payments are stable.
    • Omaxe's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
    • Omaxe's dividend is below the markets top 25% of dividend payers in India (3.08%).

    health

    thumbs up icon

    Pros

    • Omaxe is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
    • Omaxe is profitable, therefore cash runway is not a concern.
    • Omaxe is profitable, therefore cash runway is not a concern.
    • Debt is well covered by operating cash flow (70%, greater than 20% of total debt).
    • Debt is covered by short term assets, assets are 9x debt.
    • Omaxe's cash and other short term assets cover its long term commitments.
    • Omaxe earns more interest than it pays, coverage of interest payments is not a concern.
    thumbs up icon

    Cons

    • The level of debt compared to net worth has increased over the past 5 years (29.1% vs 58.4% today).
    • Omaxe's level of debt (58.4%) compared to net worth is high (greater than 40%).
    • High level of physical assets or inventory.

    management

    thumbs up icon

    Pros

    • Mohit's remuneration is lower than average for companies of similar size in India.
    thumbs up icon

    Cons

    • The average tenure for the Omaxe board of directors is less than 3 years, this suggests a new board.
    • Mohit's compensation has increased by more than 20% in the past year whilst earnings fell less than 20%.
    • The average tenure for the Omaxe management team is less than 2 years, this suggests a new team.

    misc

    thumbs up icon

    Pros

      thumbs up icon

      Cons

      • Omaxe is not covered by any analysts.
      • Omaxe has significant price volatility in the past 3 months.

      past

      thumbs up icon

      Pros

        thumbs up icon

        Cons

        • Omaxe's 1-year earnings growth is negative, it can't be compared to the 5-year average.
        • Omaxe's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
        • Omaxe used its assets less efficiently than the IN Real Estate industry average last year based on Return on Assets.
        • Omaxe's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
        • Omaxe has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
        • Omaxe's 1-year earnings growth is negative, it can't be compared to the IN Real Estate industry average.

        value

        thumbs up icon

        Pros

        • Omaxe's share price is below the future cash flow value, and at a moderate discount (> 20%).
        • 532880 outperformed the Real Estate industry which returned -24.3% over the past year.
        • 532880 outperformed the Market in India which returned -14.5% over the past year.
        • BSE:532880 is up 21.9% outperforming the Real Estate industry which returned 13.9% over the past month.
        • BSE:532880 is up 21.9% outperforming the market in India which returned 8% over the past month.
        thumbs up icon

        Cons

        • Omaxe's share price is below the future cash flow value, but not at a substantial discount (< 40%).
        • Omaxe is overvalued based on assets compared to the IN Real Estate industry average.
        • Omaxe is overvalued based on earnings compared to the IN Real Estate industry average.
        • Omaxe is overvalued based on earnings compared to the India market.

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Explore

        Calculatorsfooter arrow down icon
        Popular Calculatorsfooter arrow down icon
        Group Stocksfooter arrow down icon

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800